---
layout: post
title: "Determination That OFIRMEV (Acetaminophen) Injection, 1,000 Milligrams/100 Milliliters (10 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness"
date: 2026-02-05 18:35:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-00792
original_published: 2023-01-18 00:00:00 +0000
significance: 8.00
---

# Determination That OFIRMEV (Acetaminophen) Injection, 1,000 Milligrams/100 Milliliters (10 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** January 18, 2023 00:00 UTC
**Document Number:** 2023-00792

## Summary

The Food and Drug Administration (FDA, Agency, or we) has determined that OFIRMEV (acetaminophen) injection, 1,000 milligrams (mg)/100 milliliters (mL) (10 mg/mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for acetaminophen injection, 1,000 mg/100 mL (10 mg/mL), if all other legal and regulatory requirements are met.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/01/18/2023-00792/determination-that-ofirmev-acetaminophen-injection-1000-milligrams100-milliliters-10)
- API: https://www.federalregister.gov/api/v1/documents/2023-00792

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
